2-methoxyestradiol has been researched along with Cirrhosis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Huang, N; Jiang, QG; Lin, JQ; Yan, LY; Yang, WZ; Zheng, H | 1 |
| Bastacky, SI; Jackson, EK; Salah, E; Tofovic, SP | 1 |
| Diaz-Arrastia, CR; Kamel, MW; Kilic, GS; Salama, SA | 1 |
3 other study(ies) available for 2-methoxyestradiol and Cirrhosis
| Article | Year |
|---|---|
Effect and mechanism of pirfenidone combined with 2-methoxy-estradiol perfusion through portal vein on hepatic artery hypoxia-induced hepatic fibrosis.
Topics: 2-Methoxyestradiol; Animals; Collagen; Fibrosis; Hepatic Artery; Hypoxia; Liver Cirrhosis; Matrix Metalloproteinase 2; Perfusion; Portal Vein; Rats; Rats, Sprague-Dawley; Tissue Inhibitor of Metalloproteinase-1; Transforming Growth Factor beta1 | 2023 |
2-Methoxyestradiol Attenuates Angiotensin II-Induced Hypertension, Cardiovascular Remodeling, and Renal Injury.
Topics: 2-Methoxyestradiol; Angiotensin II; Animals; Blood Pressure; Fibrosis; Glomerular Filtration Rate; Hypertension; Hypertrophy, Left Ventricular; Isoproterenol; Kidney; Kidney Diseases; Male; Rats, Sprague-Dawley; Renin-Angiotensin System; Vascular Remodeling; Ventricular Function, Left; Ventricular Remodeling | 2019 |
2-Methoxyestradiol causes functional repression of transforming growth factor β3 signaling by ameliorating Smad and non-Smad signaling pathways in immortalized uterine fibroid cells.
Topics: 2-Methoxyestradiol; Cell Line, Transformed; Cell Nucleus; Down-Regulation; Drug Evaluation, Preclinical; Estradiol; Female; Fibrosis; Humans; Leiomyoma; Phosphorylation; Protein Binding; Protein Transport; Signal Transduction; Smad Proteins; Transforming Growth Factor beta3; Tubulin | 2012 |